Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (17) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (189) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (2) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (147) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Röefzaad, Claudia (1) (-) Torke, Sebastian Dr. (4) 2008 (1) 2022 (1) 2023 (1) 2024 (2) AG Müller/Dechend (ECRC) (50) Anchored Signalling (13) Animal Phenotyping (4) Chromatin (dys)function in disease (1) Clinical Research Unit (1) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (1) Electron Microscopy (1) Genetics and Genomics of Cardiovascular Diseases (6) Genome Engineering & Disease Models (3) Genomics (2) Host-microbiome factors in cardiovascular disease (2) Hypertension-caused End-Organ Damage (50) Hypertension-Mediated End-Organ Damage (50) Immune Regulation and Cancer (3) Integrative Vascular Biology (1) Mathematical Modelling of Cellular Processes (4) Mobile DNA (1) Molecular Biology of Peptide Hormones (10) Molecular Immunology and Gene Therapy (1) Molecular Pathways in Cortical Development (1) Myology (1) Pluripotent Stem Cells (2) Proteome Dynamics (2) Proteomics (1) Stem Cell Modeling of Development and Disease (20) Structural Biology of Membrane-Associated Processes (3) Synaptic Transmission and Plasticity (1) Transgenics (3) Translational Bioinformatics (1) (-) Translational Oncology of Solid Tumors (5) 5 Results: Active Filter: Röefzaad, ClaudiaTorke, Sebastian Dr.Translational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest July 15, 2008 / Int J Cancer REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis C. Astrosini C. Roeefzaad Y.Y. Dai B.K. Dieckgraefe T. Joens W. Kemmner April 01, 2023 / JAMA Neurol Targeting B cells and microglia in multiple sclerosis with Bruton tyrosine kinase inhibitors: a review S. Dybowski S. Torke M.S. Weber October, 2022 / CNS drugs Bruton's tyrosine kinase inhibitors in multiple sclerosis: pioneering the path towards treatment of progression? A. Geladaris S. Torke M.S. Weber March 28, 2024 / Cancers Immune response and metastasis-links between the metastasis driver MACC1 and cancer immune escape strategies S. Torke W. Walther U. Stein April 24, 2024 / Acta Neuropathol BTK inhibition limits microglia‑perpetuated CNS inflammation and promotes myelin repair A. Geladaris S. Torke D. Saberi Y.B. Alankus F. Streit S. Zechel C. Stadelmann-Nessler A. Fischer U. Boschert D. Häusler M.S. Weber
July 15, 2008 / Int J Cancer REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis C. Astrosini C. Roeefzaad Y.Y. Dai B.K. Dieckgraefe T. Joens W. Kemmner
April 01, 2023 / JAMA Neurol Targeting B cells and microglia in multiple sclerosis with Bruton tyrosine kinase inhibitors: a review S. Dybowski S. Torke M.S. Weber
October, 2022 / CNS drugs Bruton's tyrosine kinase inhibitors in multiple sclerosis: pioneering the path towards treatment of progression? A. Geladaris S. Torke M.S. Weber
March 28, 2024 / Cancers Immune response and metastasis-links between the metastasis driver MACC1 and cancer immune escape strategies S. Torke W. Walther U. Stein
April 24, 2024 / Acta Neuropathol BTK inhibition limits microglia‑perpetuated CNS inflammation and promotes myelin repair A. Geladaris S. Torke D. Saberi Y.B. Alankus F. Streit S. Zechel C. Stadelmann-Nessler A. Fischer U. Boschert D. Häusler M.S. Weber